No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast
Next report date
Report period
Q1 2024
EPS estimate
−0.66USD
Revenue estimate
—
Market capitalization
1.44 BUSD
—
—
−2.36USD
−188.92 MUSD
—
59.28 M
Beta (1Y)
1.79
About Day One Biopharmaceuticals, Inc.
Sector
CEO
Jeremy Bender
Headquarters
Brisbane
Website
Employees (FY)
155
Founded
2018
FIGI
BBG00V1KSN04
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
How to open positions (workflow)?In the picture you can see my pyramiding staggered stop strategy. Low at comments for a link where you can read more about this!
Education
11
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Stock brokers
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
Featured
Stocks, Futures
4.4Very Good
Learn more
Interactive Brokers
4.4Very Good
Learn more
Frequently Asked Questions
The current price of
DAWN
is
17.10
USD
— it has increased by
3.76
% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
Day One Biopharmaceuticals, Inc.
stocks are traded under the ticker
DAWN
.
Day One Biopharmaceuticals, Inc.
is going to release the next earnings report on
May 9, 2024
. Keep track of upcoming events with our Earnings Calendar.
DAWN
stock is
7.78
% volatile and has beta coefficient of
1.79
. Check out the list of the most volatile stocks — is
Day One Biopharmaceuticals, Inc.
there?
DAWN
earnings for the last quarter are
−0.54
USD
per share, whereas the estimation was
−0.59
USD
resulting in a
7.80
% surprise. The estimated earnings for the next quarter are
−0.57
USD
per share. See more details about
Day One Biopharmaceuticals, Inc. earnings.
Yes, you can track
Day One Biopharmaceuticals, Inc. financialsin yearly and quarterly reports right on TradingView.
DAWN
stock has risen by
9.76
% compared to the previous week, the month change is a
7.61
% rise, over the last year
Day One Biopharmaceuticals, Inc.
has showed a
36.91
% increase.
DAWN
net income for the last quarter is
−54.51 M
USD
, while the quarter before that showed
−46.15 M
USD
of net income which accounts for
−18.12
% change. Track more
Day One Biopharmaceuticals, Inc. financial statsto get the full picture.
Today
Day One Biopharmaceuticals, Inc.
has the market capitalization of
1.49 B
, it has increased by
5.27
% over the last week.
No,
DAWN
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks,
DAWN
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
Day One Biopharmaceuticals, Inc.
stock right from TradingView charts — choose your broker and connect to your account.
DAWN
reached its all-time high on
Sep 7, 2021
with the price of
28.70
USD
, and its all-time low was
5.44
USD
and was reached on
May 27, 2022
.
See other stocks reaching their highest and lowest prices.
As of
May 1, 2024
, the company has
155.00
employees. See our rating of the largest employees — is
Day One Biopharmaceuticals, Inc.
on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
Day One Biopharmaceuticals, Inc.
technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
Day One Biopharmaceuticals, Inc.
stock shows the buy signal. See more of
Day One Biopharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on
Day One Biopharmaceuticals, Inc.
future price: according to them,
DAWN
price has a max estimate of
50.00
USD
and a min estimate of
10.00
USD
. Read a more detailed
Day One Biopharmaceuticals, Inc. forecast: see what analysts think of
Day One Biopharmaceuticals, Inc.
and suggest that you do with its stocks.